Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Inge Marie Svane, Herlev Hospital
ClinicalTrials.gov Identifier:
NCT00978913
First received: September 16, 2009
Last updated: August 18, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)